Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

FDA Greenlights Soliris for Rare Autoimmune Disease

The U.S. FDA gave Alexion Pharmaceuticals a thumbs-up for Soliris (eculizumab) to treat neuromyelitis optica spectrum disorder in adults that express a specific biomarker.

Read More »

Sangamo shares dive after poor early-stage trial data

Sangamo Therapeutics Inc.’s shares sank 27 percent after the company’s gene-editing drug failed to show promise in an early-stage trial testing for patients with ultra-rare disorders.

Read More »

Pixium Vision announces its PRIMA chip successfully met interim study endpoints for dry AMD

Pixium Vision announced that the bioelectronics company’s subretinal PRIMA system met the endpoints of the feasibility study, at interim 6 months follow-up after implantation and rehabilitation for patients with advanced dry age-related macular degeneration (AMD).

Read More »

Using Lab-Grown Retinas, Researchers Take Steps Toward Curing Colorblindness

Researchers at Johns Hopkins University, the University of California, San Diego (UCSD), and the National Institute of Mental Health grew retinas in Petri dishes and discovered fundamental factors involved in the development of vision and color vision.

Read More »

ProQR childhood blindness drug succeeds in early study

An interim analysis of an early-stage trial showed that ProQR Therapeutics NV’s experimental treatment for a rare form of childhood blindness improved vision.

Read More »

Clearside Biomedical’s eye treatment succeeds study

Clearside Biomedical Inc. said the drug developer’s treatment helped improve vision in patients with fluid buildup in the eye in a late-stage study.

Read More »

After solar eclipse, Americans’ eyes seem mostly none the worse

Eye doctors who had braced themselves for at least a few patients after a dazzling solar eclipse swept the United States cautiously exhaled, with some hospitals reporting zero cases of damaged vision so far.

Read More »

Smartphone Controlled Vision is Coming

For the first time, EPGL reveals the “Omega” contact lens under development with InWith Corp. The patent pending “Omega” is designed to correct vision anytime by changing the curvature of the lenses on-demand, via smart phone or other mobile devices.

Read More »

Artificial vision device may help nearly blind people

People with very poor vision may benefit from using a device that recognizes faces, money and text, a small study suggests.

Read More »

Two Indian states halt sales of Roche’s Avastin drug

Two Indian states have put sales of Swiss drugmaker Roche’s blockbuster drug Avastin on hold, officials said on Tuesday, after it hampered the vision of 15 patients who used it for a condition it is not officially meant to treat.   Avastin is a cancer drug but is often used by doctors to treat vision […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!

Subscribe

Ad Right Bottom